Novel spectrophotometric method for the assay of captopril in dosage forms using 2,6-dichloroquinone-4-chlorimide

International Journal of Biomedical Science

Volumn 4, Issue 2, 2008, Pages 147-154

  El Enany, Nahed ^a   Belal, Fathalla ^a   Rizk, Mohamed ^b  

^a MANSOURA UNIVERSITY   (Egypt)

^b Ein Helwan   (Egypt)

Author keywords

2,6 dichloroquinone 4 chlorimide (DCQ); Captopril; Dosage forms; Spectrophotometry

Indexed keywords

2,6 DICHLOROQUINONE 4 CHLORIMIDE; CAPTOPRIL; CAPTOPRIL PLUS HYDROCHLOROTHIAZIDE; DIMETHYL SULFOXIDE; REAGENT;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG DOSAGE FORM; INTERMETHOD COMPARISON; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SENSITIVITY ANALYSIS; SPECTROPHOTOMETRY; TABLET;

EID: 70449355609     PISSN: 15509702     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. K. Parfitt, in "Martindale, The Complete Drug Reference",, 32nd edn., The Pharmaceutical Press, Massachusts (1999) 720, 836.
2. S.A. Shama, A. E. Amin, H. Omara. J Quantitative Spectroscopy & Radiative Transfer. vol. 102, pp. 261-268, 2006.
3. A. M. Pimenta, A. N. Araújo, M. Conceição B.S. Montenegro "Sequential injection analysis of captopril based on colorimetric and potentiometric detection" Anal. Chim. Acta. vol. 438, pp.31-38, 2001.
4. A. F. M. El-Walily, O. A. Razak, S. F. Belal, R. S. Bakry, J.Pharm. Biomed. Anal. vol. 21, pp. 439, 1999.
5. S. J. Hosseinimehr, P. Ebrahimi, N. Hassani, P. Mirzabeigi and M. Amini, "Spectrophotometric determination of captopril with DTNB reagent in pharmaceutical formulation," Boll Chim Farm. vol.143, 249-251, 2004.
6. C. S. P. Sastry, K. R. Srinivas and K.M.M.K. Prasad.,"spectrophotometric determination of bio-active compounds in commercial samples with nitrous acid and cresyl fast violet acetate," Anal. Lett., vol. 29, pp. 1329-1349, 1996.
7. G. H. Huan, H. Liu, Y. H. Shia, G. W. Le." Direct spectrophotometric measurement of angiotensin I-converting enzyme inhibitory activity for screening bioactive peptides" J. Pharm. Biomed. Anal. vol. 37, pp. 219-224, 2005.
8. C. Liu, S. Liu, H. Chen and X. Xie," Determination of captopril in tablets by gas chromatography(GC)," SePu., vol.16, 82-83, 1999.
9. M. E. Franklin, R. S. Addison, P. V. Baker and W. D. Hooper Improved analytical procedure for the measurement of captopril in human plasma by gas chromatography - mass spectrometry and its application to pharmacokinetic studies," J Chromatogr B Biomed Sci Appl. vol. 705, pp. 47-54, 1998.
10. T. Huang, Z. He, B. Yang, L. Shao, X. Zheng and G. Duan, "Simultaneous determination of captopril and hydrochlorothiazide in human plasma by reverse-phase HPLC from linear gradient elution," J. Pharm. Biomed. Anal. vol. 41, pp.644-648, 2006.
11. T. Nishikawa, R. Abe, Y.Sudo, A.Yamada and K. Tahara, "HPLC profile of captopril disulfide that undergoes reversible cis-trans conversion among three isomers," Anal Sci., vol. 20, pp. 1395-1398, 2004.
12. A. El-Gindy, S.Emara and G. M.Hadad," Determination of certain drugs in binary mixtures formulations by second derivative ratio spectrophotometry and LC," Farmaco. vol. 59, pp.703-712, 2004.
13. D. Zhong, X. Li, A.Wang and X. Chen, "Determination of captopril plus its disulfide metabolites in human plasma," Yao Xue Xue Bao., vol. 33, pp. 605-609, 1998.
14. J. Russell, J. A. Mckeown, C. Hensman, W.E. Smith, J. Reglinski, "HPLC determination of biologically active thiols using precolumn derivatization with 5,5′(2-nitobenzoic acid)," J. Pharm. Biomed. Anal. vol. 15, pp. 1757-1763, 1997.
15. M. Bahmaei, A. Khosravi, C. Zamiri, A. Massoumi, M. Mahmoudian, "Determination of captopril in human serum by HPLC using solid-phase extraction," J.Pharm. Biomed. Anal.vol. 15, pp. 1181-1186, 1997.
16. E. Bald and S. Sypniewski, "Determination of thiol drugs in pharmaceutical formulations as their S-pyridinium derivatives by HPLC with Ultra-Violet detection," Fresenius, J.Anal.Chem., vol. 358, pp. 554-555, 1997.
17. R. J. Kok, J. Visser, F. Moolenaar, D. de-Zeeuw, D. K. F. Meijer, "Bio-analysis of captopril: two sensitive HPLC methods with pre-or post-column fluorescent labeling," J. Chromatogr. Biomed. Appl., vol. 693 pp. 181-189, 1997.
18. G. Favaro and M. Fiorani, "Determination of pharmaceutical thiols by liquid chromatography with electrochemical detection: use of an electrode with conductive carbon cement matrix, chemically modified with cobalt phthalocyanine, Anal. Chim. Acta. vol. 332, pp. 249-255, 1996.
19. E. Bald, S. Sypniewski, J. Drzewoski, M. Stepien, "Application of 2-halopyridinium salts as ultra-violet derivatization reagent and solid phase extraction for determination of captopril in human plasma by HPLC, J. Chromatogr. Biomed. Appl., vol. 681, pp. 283-289, 1996.
20. R. I. Stefan, J.F. Van-Staden, H.Y. Aboul-Enein, "On-line assay of S-captopril using an amperometric biosensor/sequential injection system," Anal. Chim. Acta. vol. 411, pp. 51-56, 2000.
21. R. I. Stefan, J.F. Van-Staden, H.Y. Aboul-Enein, "Simultaneous detection of (S)- and (R)-captopril using sequential-injection analysis," Talanta. vol. 51, pp.969-975, 2000.
22. X. Ioannides, A. Economou and A. Voulgaropoulos, "A study of the determination of the hypertensive drug captopril by square wave cathodic adsorptive stripping voltammetry," J Pharm Biomed Anal. vol. 33, pp.309-316, 2003.
23. R. I. Stefan, J.F. Van-Staden, H.Y. Aboul-Enein, "A new construction for a potentiometric, enantioselective membrane electrode-its utilization to the S-captopril assay," Talanta. vol. 48, pp. 1139-1143, 1999.
24. S. M. Al-Ghannam, "Differential electrolytic potentiometric determination of some thiol compounds in their dosage forms," Farmaco., vol. 59, pp. 331-334, 2004.
25. J. Du, Y Li. And J Lu., "Flow injection chemiluminescence determination of captopril based on its enhancing effect on the luminol-ferricyanide/ferrocyanide reaction," Luminescence. Vol. 17, pp. 165-167, 2002.
26. T. Perez-Ruiz, C.Martinez-Lozano and R.Galera, "Development and validation of a capillary electrophoresis method with laser-induced fluorescence detection for the determination of captopril in human urine and pharmaceutical preparations," Electrophoresis. vol. 27, pp. 2310-2316, 2006.
27. United States Pharmacopeia 24; National Formulary 19, Rockville, USP(2000) p. 296, 297.
28. G. G. Mohamed, S. M., Khalil, M. A. Zayed and M.A. El-Shall, "2,6-Dichloroquinone chlorimide and 7,7,8,8-tetracyanoquinodimethane reagents for the spectrophotometric determination of salbutamol in pure and dosage forms," J. Pharm. Biomed. Anal., vol. 28, pp. 1127-1133, 2002.
29. F.A.Aly, F. Belal, M.I. Walash, "Colorimetric determination of prenalterol hydrochloride in dosage forms," J. Pharm. Biomed. Anal., vol. 12, 955-958, 1994.
30. A. A. Al-Majed, Spectrophotometric estimation of D-penicillamine in bulk and dosage forms using 2,6-dichloroquinone-4-chlorimide (DCQ). J. Pharm. Biomed. Anal., vol. 21, pp.:827-833, 1999.
31. M. S. Refat and A.M.El-Didamony, "Spectrophotometric and electrical studies of charge-transfer complexes of sodium flucloxacillin with pi-acceptors," Spectrochim Acta.vol. 65, pp. 732-741, 2006.
32. S.S. Abbas, L.I. Bebawy, L.A. Fattah and H.H. Refaat, "Spectrophotometric stability-indicating methods for the determination of Leflunomide in the presence of its degradates," J. AOAC Int. vol. 89, pp. 1524-1531, 2006.
33. D. D. Perrin & B.Dempsey (1974) "Buffers for pH and Metal Ion Control" Chapter 10, Wiley, New York. (pp 134,147, 149).
34. Guidance for Industry Bioanalytical method Validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Rockville, MD, May. 2001 http://www.fda.gov/ eder/guidance/4252fnl.pdf (accessed September 1, 2004).
35. J. N. Miller and J. C. Miller "Statistics and Chemometrics for Analytical Chemistry", 5th ed., Prentice Hall, England, 2005.p. 256.